{"id":"https://openalex.org/W2044366183","doi":"https://doi.org/10.1158/1535-7163.targ-11-c212","title":"Abstract C212: A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats.","display_name":"Abstract C212: A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats.","publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W2044366183","doi":"https://doi.org/10.1158/1535-7163.targ-11-c212","mag":"2044366183"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-11-c212","doi":"https://doi.org/10.1158/1535-7163.targ-11-c212","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-c212","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035532117","display_name":"Dan Zhou","orcid":"https://orcid.org/0000-0003-0426-0339","observed_orcids":["https://orcid.org/0000-0003-0426-0339"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Zhou","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yuan Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuan Liu","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002679692","display_name":"Josephine Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine Ye","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102508194","display_name":"Weiwen Ying","orcid":"https://orcid.org/0000-0002-5879-3782","observed_orcids":["https://orcid.org/0000-0002-5879-3782"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weiwen Ying","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100669787","display_name":"Shijie Zhang","orcid":"https://orcid.org/0000-0002-8041-0581","observed_orcids":["https://orcid.org/0000-0002-8041-0581"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shijie Zhang","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035598007","display_name":"Luisa Shin Ogawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luisa Shin Ogawa","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062079325","display_name":"Takayo Inoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takayo Inoue","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036758613","display_name":"Noriaki Tatsuta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noriaki Tatsuta","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109967882","display_name":"Yumiko Wada","orcid":"https://orcid.org/0009-0004-3645-2997","observed_orcids":["https://orcid.org/0009-0004-3645-2997"]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yumiko Wada","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028616307","display_name":"Andrew J. Sonderfan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Sonderfan","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111537027","display_name":"Keizo Koya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keizo Koya","raw_affiliation_strings":["1Synta Pharmaceuticals Corp., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Synta Pharmaceuticals Corp., Lexington, MA","institution_ids":["https://openalex.org/I4210158135"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210158135"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"11_Supplement","first_page":"C212","last_page":"C212"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.05979999899864197,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13869","display_name":"Ocular and Laser Science Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.9670000076293945},{"id":"https://openalex.org/keywords/photoreceptor-degeneration","display_name":"photoreceptor degeneration","score":0.9449999928474426},{"id":"https://openalex.org/keywords/17-dmag","display_name":"17-DMAG","score":0.8939999938011169},{"id":"https://openalex.org/keywords/17-aag","display_name":"17-AAG","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ganetespib","display_name":"ganetespib","score":0.8880000114440918},{"id":"https://openalex.org/keywords/drug-elimination","display_name":"drug elimination","score":0.6029999852180481},{"id":"https://openalex.org/keywords/retinal-histopathology","display_name":"retinal histopathology","score":0.6710000038146973},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5199999809265137},{"id":"https://openalex.org/keywords/photoreceptor-cell-death","display_name":"photoreceptor cell death","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2781040256","wikidata":"https://www.wikidata.org/wiki/Q7316761","display_name":"Retinal degeneration","level":3,"score":0.657101035118103},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.6354398131370544},{"id":"https://openalex.org/C2777093970","wikidata":"https://www.wikidata.org/wiki/Q169342","display_name":"Retina","level":2,"score":0.614464521408081},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6065706014633179},{"id":"https://openalex.org/C2780916184","wikidata":"https://www.wikidata.org/wiki/Q748049","display_name":"Photoreceptor cell","level":3,"score":0.5487757325172424},{"id":"https://openalex.org/C205260736","wikidata":"https://www.wikidata.org/wiki/Q418939","display_name":"Heat shock protein","level":3,"score":0.5020244121551514},{"id":"https://openalex.org/C2779113765","wikidata":"https://www.wikidata.org/wiki/Q681562","display_name":"Electroretinography","level":3,"score":0.49584731459617615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4635794162750244},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4474482834339142},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4276901185512543},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34645578265190125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30178549885749817},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14261406660079956},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.10081398487091064},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-11-c212","doi":"https://doi.org/10.1158/1535-7163.targ-11-c212","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-c212","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2073761249","https://openalex.org/W2025483770","https://openalex.org/W2000950187","https://openalex.org/W2768124098","https://openalex.org/W2131127039","https://openalex.org/W2045604189","https://openalex.org/W2277127450","https://openalex.org/W2097382830","https://openalex.org/W2968972472","https://openalex.org/W2165563508"],"abstract_inverted_index":{"Abstract":[0],"In":[1,35,83,123,180,264,381],"addition":[2],"to":[3,24,61,67,155,214,397],"regulating":[4],"a":[5,86,118,238,259,303,347],"number":[6,119],"of":[7,19,81,120,182,247,271,293,331,374,409,439],"oncogenic":[8],"client":[9],"proteins,":[10],"the":[11,17,33,62,128,184,210,248,256,269,277,299,354,389,440],"Hsp90":[12,39,88,113,148,376,383,393,410],"molecular":[13],"chaperone":[14],"also":[15],"controls":[16],"folding":[18],"key":[20],"signaling":[21],"molecules":[22],"required":[23],"maintain":[25],"normal":[26],"cell":[27,71,232],"function":[28],"in":[29,76,91,106,138,152,161,209,226,255,302,336,365,379,388],"many":[30],"organs,":[31],"including":[32,47],"retina.":[34],"human":[36],"clinical":[37,98,227],"trials":[38],"inhibition":[40,394],"has":[41,95],"been":[42,224,296],"associated":[43,236],"with":[44,150,188,237,268,412],"visual":[45,221,273],"disorders":[46],"blurred":[48],"vision,":[49],"flashes,":[50],"delayed":[51],"light/dark":[52],"accommodation,":[53],"and":[54,70,111,135,145,175,190,216,234,258,266,316,340,358,368,391,427,446],"photophobia.":[55],"These":[56],"adverse":[57],"effects":[58],"involving":[59],"injury":[60],"retina":[63,300,390],"may":[64,403],"be":[65,370,404],"attributable":[66],"photoreceptor":[68,136,231,285],"degeneration":[69,137,325,343],"death,":[72],"as":[73,372],"previously":[74],"reported":[75,225],"dogs":[77],"following":[78],"repeated":[79],"doses":[80,330],"PF-04929113.":[82],"contrast,":[84,265],"ganetespib,":[85],"potent":[87],"inhibitor":[89,149],"currently":[90],"phase":[92],"II/III":[93],"trials,":[94],"demonstrated":[96],"promising":[97],"activity":[99,154],"without":[100],"manifesting":[101],"ocular":[102,366,401],"toxicity.":[103],"This":[104],"difference":[105],"vision":[107,398],"deficits":[108],"between":[109,130],"ganetespib":[110],"other":[112],"inhibitors":[114,411],"likely":[115],"depends":[116],"on":[117],"contributing":[121],"factors.":[122],"this":[124],"study,":[125],"we":[126],"examined":[127],"relationship":[129],"retinal":[131,185,211,429],"drug":[132,249,311,414],"distribution":[133],"profiles":[134,361],"male":[139],"SD":[140],"rats":[141],"treated":[142],"with17-DMAG,":[143],"17-AAG,":[144],"STA-9056":[146,308,332],"(an":[147],"comparable":[151],"vitro":[153],"17-DMAG).":[156],"All":[157],"compounds":[158,204],"were":[159,173,195],"tested":[160],"short-term":[162],"studies":[163],"at":[164,251,276,313,329,346],"1\u20133":[165],"dose":[166,280],"levels":[167],"administered":[168],"i.v.,":[169],"At":[170,287],"necropsy,":[171],"eyes":[172],"dissected":[174],"processed":[176],"for":[177,197,219],"histopathological":[178],"examination.":[179],"subsets":[181],"animals,":[183],"tissues,":[186],"along":[187],"plasma":[189,215],"cerebrospinal":[191],"fluid":[192],"(CSF)":[193],"samples,":[194],"collected":[196],"analysis.":[198],"Our":[199,350],"results":[200],"indicate":[201],"that":[202,320,333,353,416],"all":[203],"evaluated":[205],"showed":[206,309],"greater":[207],"exposure":[208,356,425],"tissue":[212],"compared":[213],"CSF.":[217],"17-DMAG,":[218],"which":[220],"changes":[222],"have":[223],"subjects,":[228],"produced":[229],"marked":[230],"death":[233],"was":[235,321,326,344],"slow":[239],"elimination":[240,312,359],"rate":[241,360],"(at":[242],"6":[243,288,314],"hrs":[244,315],"post-dose,":[245],"50%":[246],"present":[250],"30":[252],"min":[253],"remained":[254],"retina)":[257],"high":[260],"retina/plasma":[261,424],"(R/P)":[262],"ratio.":[263,306],"consistent":[267],"absence":[270],"clinically-reported":[272],"changes,":[274],"17-AAG":[275,294],"maximum":[278],"tolerated":[279],"did":[281],"not":[282,327,419],"produce":[283],"detectable":[284],"injury.":[286],"hr":[289],"post":[290],"dose,":[291],"94%":[292],"had":[295],"eliminated":[297],"from":[298],"resulting":[301],"low":[304],"R/P":[305,318,355],"Finally,":[307],"79%":[310],"an":[317,385],"ratio":[319,357],"moderately":[322],"low.":[323],"Photoreceptor":[324],"observed":[328],"are":[334],"active":[335],"animal":[337],"tumor":[338],"models,":[339],"only":[341],"minimal":[342],"seen":[345],"higher":[348],"dose.":[349],"findings":[351],"suggest":[352],"play":[362],"crucial":[363],"roles":[364],"toxicity":[367,402],"can":[369,395],"used":[371],"indicators":[373],"potential":[375],"inhibitor-induced":[377],"damage":[378],"rats.":[380],"summary,":[382],"plays":[384],"important":[386],"role":[387],"prolonged":[392],"lead":[396],"disorders.":[399],"However,":[400],"successfully":[405],"minimized":[406],"by":[407],"administration":[408],"favorable":[413],"properties":[415],"include,":[417],"although":[418],"necessarily":[420],"limited":[421],"to,":[422],"lower":[423],"ratios":[426],"faster":[428],"elimination.":[430],"Citation":[431],"Format:":[432],"{Authors}.":[433],"{Abstract":[434],"title}":[435],"[abstract].":[436],"In:":[437],"Proceedings":[438],"AACR-NCI-EORTC":[441],"International":[442],"Conference:":[443],"Molecular":[444],"Targets":[445],"Cancer":[447,459],"Therapeutics;":[448],"2011":[449],"Nov":[450],"12-16;":[451],"San":[452],"Francisco,":[453],"CA.":[454],"Philadelphia":[455],"(PA):":[456],"AACR;":[457],"Mol":[458],"Ther":[460],"2011;10(11":[461],"Suppl):Abstract":[462],"nr":[463],"C212.":[464]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2016-06-24T00:00:00"}